Glucocorticoid Receptor Antagonism Improves Glucose Metabolism in a Mouse Model of Polycystic Ovary Syndrome

December 2023 in “ Journal of the Endocrine Society ”

Sheng Li, Zhixiong Ying, Max Gentenaar, Patrick C.N. Rensen, Sander Kooijman, Jenny A. Visser, Onno C. Meijer, Jan Kroon

glucocorticoid receptor GR dihydrotestosterone DHT polycystic ovary syndrome PCOS hyperglycemia glucose tolerance high blood sugar

TLDR Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

In a study using a mouse model of polycystic ovary syndrome (PCOS) induced by chronic dihydrotestosterone (DHT) exposure, researchers found that glucocorticoid receptor (GR) signaling is upregulated in the liver and white adipose tissues. Preventive administration of a selective GR antagonist improved glucose metabolism by alleviating DHT-induced hyperglycemia and restoring glucose tolerance, although it did not significantly affect total fat mass or lipid accumulation. This suggests that GR activation may contribute to glucose metabolism issues in PCOS.

View this study on academic.oup.com →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

research Hair Cortisol in Polycystic Ovary Syndrome

2 citations, June 2022 in “Scientific reports”

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

research Androgens and Ovarian Function: Translation from Basic Discovery Research to Clinical Impact

55 citations, May 2019 in “Journal of Endocrinology”

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

research Polycystic Ovary Syndrome: Overview and Management

87 citations, July 2018 in “Nursing Clinics of North America”

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

research Metabolic Risk in PCOS: Phenotype and Adiposity Impact

162 citations, January 2015 in “Trends in Endocrinology and Metabolism”

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

research Polycystic Ovary Syndrome: Etiology, Pathogenesis, and Diagnosis

991 citations, January 2011 in “Nature Reviews Endocrinology”

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

research Targeting the Pre-Receptor Metabolism of Cortisol as a Novel Therapy in Obesity and Diabetes

70 citations, March 2010 in “The Journal of Steroid Biochemistry and Molecular Biology”

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

research The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report

1540 citations, October 2008 in “Fertility and Sterility”

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Similar Research

5 / 1000+ results

research Dihydrotestosterone Induces Arterial Stiffening in Female Mice

January 2024 in “Biology of sex differences”

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

research Molecular Genetic and Endocrine Mechanisms of Hair Growth

51 citations, January 2003 in “Hormone Research in Paediatrics”

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

research 5α-Reduced Glucocorticoids: A Story of Natural Selection

46 citations, September 2011 in “Journal of Endocrinology”

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

11α-Hydroxyprogesterone, a Potent 11β-Hydroxysteroid Dehydrogenase Inhibitor, Is Metabolized by Steroid-5α-Reductase and Cytochrome P450 17α-Hydroxylase/17,20-Lyase to Produce C11α-Derivatives of 21-Deoxycortisol and 11-Hydroxyandrostenedione In Vitro

research 11α-Hydroxyprogesterone, a Potent 11β-Hydroxysteroid Dehydrogenase Inhibitor, Is Metabolized by Steroid-5α-Reductase and Cytochrome P450 17α-Hydroxylase/17,20-Lyase to Produce C11α-Derivatives of 21-Deoxycortisol and 11-Hydroxyandrostenedione In Vitro

7 citations, April 2019 in “The Journal of Steroid Biochemistry and Molecular Biology”

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

research Pharmacodynamic Evaluation: Endocrinology

January 2017

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Glucocorticoid Receptor Antagonism Improves Glucose Metabolism in a Mouse Model of Polycystic Ovary Syndrome

Research cited in this study

research Hair Cortisol in Polycystic Ovary Syndrome

research Androgens and Ovarian Function: Translation from Basic Discovery Research to Clinical Impact

research Polycystic Ovary Syndrome: Overview and Management

research Metabolic Risk in PCOS: Phenotype and Adiposity Impact

research Polycystic Ovary Syndrome: Etiology, Pathogenesis, and Diagnosis

research Targeting the Pre-Receptor Metabolism of Cortisol as a Novel Therapy in Obesity and Diabetes

research The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report

Related Community Posts Join

community New and Interesting HairLoss Studies/Papers/Reviews

community NootBro Recommendations… How Do We Feel

community We Need A Solution For The Inflammatory Response related To AGA

community Pyrilutamide is working but not strong enough, how long should i wait for noticeable results?

community AA and Hirsutism but T levels are normal

community No luck with meds, Check your Cortisol.